Within-subject biological variation in disease: collated data and clinical consequences

Quantitative data on the components of biological variation (BV) are used for several purposes, including calculating the reference change value (RCV) required for the assessment of the significance of changes in serial results in an individual. Pathology may modify the set point in diseased patients and, more importantly, the variation around that set-point. Our aim was to collate all published BV data in situations other than health. We report the within-subject coefficient of variation (CVI) for 66 quantities in 34 disease states. We compared the results with the CVI determined in healthy individuals and examined whether the data derived in specific diseases could be useful for clinical applications. For the majority of quantities studied, CVI values are of the same order in disease and health: thus the use of RCV derived from healthy subjects for monitoring patients would be reasonable. However, for a small number of quantities considered to be disease specific markers, the CVI differed from those in health. This could mean that RCV derived from healthy CVI may be inappropriate for monitoring patients in certain diseases. Hence, disease-specific RCVs may be clinically useful.

[1]  C. Fraser,et al.  Short-term biological variation of plasma analytes in renal disease. , 1983, Clinical Chemistry.

[2]  A. Griesmacher,et al.  Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer. , 1995, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[3]  W. Vermaak,et al.  Biological variation in sweat sodium chloride conductivity , 2002, Annals of clinical biochemistry.

[4]  J. Queraltó,et al.  Reference Change Value for HbA1c in Patients with Type 2 Diabetes Mellitus , 2000, Clinical chemistry and laboratory medicine.

[5]  R. Lauzurica,et al.  Are equally spaced specimen collections necessary to assess biological variation? Evidence from renal transplant recipients. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[6]  C. Fraser,et al.  Components of Variance of Some Plasma Constituents in Patients with Myocardial Infarction , 1982, Annals of clinical biochemistry.

[7]  W. Hölzel.  Intra-individual variation of analytes in serum from patients with chronic liver diseases. , 1987, Clinical chemistry.

[8]  G. Filler,et al.  Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine. , 2005, Clinical chemistry.

[9]  R. Simó,et al.  Biological Variation of Lipoprotein(a) in a Diabetic Population. Analysis of the Causes and Clinical Implications , 2003, Clinical chemistry and laboratory medicine.

[10]  W. Hölzel.  Intra-individual variation of some analytes in serum of patients with insulin-dependent diabetes mellitus. , 1987, Clinical chemistry.

[11]  S. Meo,et al.  Evaluation of Critical Differences of CEA and CA15.3 Levels in Serial Samples from Patients Operated for Breast Cancer , 1994, The International journal of biological markers.

[12]  M. Gion,et al.  Variability of tumor markers in the follow-up of patients radically resected for breast cancer. , 1993, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[13]  W. Hölzel.  Influence of hypertension and antihypertensive drugs on the biological intra-individual variation of electrolytes and lipids in serum. , 1988, Clinical chemistry.

[14]  P. H. Petersen,et al.  Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. , 2006, Clinical chemistry.

[15]  M. Panteghini,et al.  Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[16]  P. H. Petersen,et al.  Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice. , 2005, Clinical chemistry.

[17]  C. Fraser.  Inherent biological variation and reference values , 2004, Clinical chemistry and laboratory medicine.

[18]  C. Derby,et al.  Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic. , 1992, Clinical chemistry.

[19]  P. H. Petersen,et al.  Biological variation at long-term renal post-transplantation. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[20]  C. Fraser,et al.  Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation. , 1987, Clinical chemistry.

[21]  D. Holt,et al.  Cystatin C Intrapatient Variability in Children with Chronic Kidney Disease Is Less than Serum Creatinine , 2005 .

[22]  W. Hölzel,et al.  Intra-individual variation of serum thyroxin and triiodothyronine in pregnancy. , 1988, Clinical chemistry.

[23]  R. Jung,et al.  Intra-individual variation of thyroxin, triiodothyronine, and thyrotropin in treated hypothyroid patients: implications for monitoring replacement therapy. , 1988, Clinical chemistry.

[24]  E. Sasse,et al.  Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. , 1996, Clinical chemistry.

[25]  C G Fraser,et al.  Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.

[26]  C. Ricós,et al.  The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation , 2004, Scandinavian journal of clinical and laboratory investigation.

[27]  J. Kanis,et al.  Intra-Individual Variation in Fasting Urinary Calcium- and Hydroxyproline-Creatinine Ratios Measured in Metabolic Bone Clinic Patients as Both Outpatients and Inpatients , 1994, Annals of clinical biochemistry.

[28]  J. V. D. van den Ouweland,et al.  High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. , 2004, Clinical chemistry.

[29]  R. Lauzurica,et al.  Reference change value concept combining two delta values to predict crises in renal posttransplantation. , 2001, Clinical chemistry.

[30]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[31]  J. Sundsfjord,et al.  Intra‐individual variability and longitudinal changes in glycaemic control in patients with Type 1 diabetes mellitus , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[32]  N. Guañabens,et al.  Components of biological variation of biochemical markers of bone turnover in Paget's bone disease. , 2000, Bone.

[33]  W. Hölzel.  Intra-individual variation of some analytes in serum of patients with chronic renal failure. , 1987, Clinical chemistry.

[34]  Callum G. Fraser,et al.  Biological Variation: From Principles to Practice , 2001 .

[35]  Anders Kallner,et al.  STRATEGIES TO SET GLOBAL ANALYTICAL QUALITY SPECIFICATION, IN LABORATORY MEDICINE , 1999 .

[36]  C. Ricós,et al.  Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease. , 2003, Clinical chemistry.